Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - November 2014


Advances in Cell Based Assays

11 Nov 2014 - 12 Nov 2014 - London, UK



Bookmark and Share


SMi Group invites you to attend the market leading cell based event, Advances in Cell Based Assays, taking place on 11th & 12th November in Central London.

We have worked closely with an array of industry KOLs and scientific leaders to host a packed conference agenda for the 7th annual conference this autumn

Expand your scientific horizons as we ask the questions: 

  • How have recent advances in high throughput sample expression techniques opened up new possibilities for primary HTS within the biologics industry? 
  • What are the current challenges of bioassay method development and how can we validate these with reference to cell based assays and regulatory guidelines in drug development? 
  • What is the next generation of target identification and screening technologies? 
  • How easy is it to use adult stem cells in therapeutic applications, in vitro and in vivo paradigm?
  • How can we exploit gene editing in human cell lines to provide novel, isogenic assays? 
  • How are new technologies impacting the industry? 
  • 3D cell culture, how can this be used in oncology research? 
  • What is the next generation of cell based assays?

Key Speakers Include:

  • Steve Ludbrook, Group Leader, Biological Sciences UK, RD Platform Technology & Science, GSK
  • Beverley Isherwood, Team Leader High Content Biology, Innovative Medicines, AstraZeneca R&D
  • Dr Lesley Jenkinson, Scientist 1, Medimmune
  • Dr Farnaz Fallah-Arani, Group Leader, Pharmacology, UCB
  • Neil Carragher, PhD, Principal Investigator Drug Discovery, Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh
  • Niclas Nilsson, Head of Section, Lead Discovery, LEO Pharma
  • Dr Christa Burger, Principal Scientist, Cellular Pharmacology, Merck Serono
  • Dr Marianne Uteng, PhD, Head of Cellular Models & HCB Laboratory, Discovery and Investigative Safety (DIS), Novartis
  • Anker Jon Hansen, Principal Scientist, Novo Nordisk
  • Daniel Nolan, Director of Research, Angiocrine Bioscience

For further details and to download a copy of the PDF,  visit http://www.smi-online.co.uk/goto/2014cellbasedassay36.asp 

Alternatively contact Fateja Begum on +44 (0)20 7827 6184 or email fbegum@smi-online.co.uk



Further information
Scientific News
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
HIV Susceptibility Linked to Little-Understood Immune Cell Class
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
Long-sought Discovery Fills in Missing Details of Cell 'Switchboard'
A biomedical breakthrough reveals never-before-seen details of the human body’s cellular switchboard that regulates sensory and hormonal responses.
Tracking Breast Cancer Before it Grows
A team of scientists led by University of Saskatchewan researcher Saroj Kumar is using cutting-edge Canadian Light Source techniques to screen and treat breast cancer at its earliest changes.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
DNA Damage Seen in Patients Undergoing CT Scanning
Along with the burgeoning use of advanced medical imaging tests over the past decade have come rising public health concerns about possible links between low-dose radiation and cancer.
The Light of Fireflies for Medical Diagnostics
EPFL scientists have exploited the light of fireflies in a new method that detects biological molecules without the need for complex devices and high costs.
Vital Protein in Healthy Fertilization Process Identified
Researchers at the National Institutes of Health have discovered a protein that plays a vital role in healthy egg-sperm union in mice.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!